The IL2RG gene encoding the y chain of the lymphocyte receptor for IL-2 lies in human Xql3.1 and is mutated in males with X-linked severe combined immunodeficiency (SCID). In a large Canadian pedigree genetic linkage studies demonstrated that the proband's grandmother was the source of an X-linked SCID mutation. However, her T cells did not show the expected skewed X chromosome inactivation pattern of female'carriers of SCID, despite her having one affected son and two carrier daughters with skewed X inactivation. Single strand conformation polymorphism analysis of IL2RG in the affected proband was abnormal in exon 5; sequencing revealed a nine nucleotide in-frame duplication insertion. The three duplicated amino acids included the first tryptophan of the "WSXWS" motif found in all members of the cytokine receptor gene superfamily. Mutation detection in the pedigree confirmed that the founder' grandmother's somatic cells had only normal IL2RG, and further showed that the SC1D-associated X chromosome haplotype was inherited by three daughters, one with a wild type IL2RG gene and two others with the insertional mutation. Female germ line mosaicism is unusual, but its presence in this X-linked SCID family emphasizes the limitations of genetic diagnosis by linkage as compared with direct mutation analysis. (J. Cln. Invest 1995. 95:895-899.)
Introduction
The most common form of human severe combined immunodeficiency (SCID)' is caused by mutations in the X chromosome-linked gene encoding the y chain of the interleukin-2 receptor complex (IL2RG) (1, 2) . Estimated to occur in 1 in 10,000 to 100,000 births, X-linked' SCID generally has a severe phenotype, with failure to thrive and infections leading to death before 18 mo of age unless successfully treated by bone marrow transplantation (3, 4) . Patients have very few T cells and absent mitogen responses; although B cells are often present, immunoglobulin levels are low, and specific antibody production is lacking. Skewed X chromosome inactivation in lymphocytes is a hallmark of female carriers, reflecting a selective disadvantage during growth and maturation for lymphocyte progenitors bearing a SCID mutation on the active X chromosome (5) .
Before the identification of IL2RG as the X-linked SCID gene, indirect genetic methods were used for carrier testing and prenatal prediction (6) . Linkage analysis using polymorphic DNA markers in SCID families had positioned the disease locus in the proximal long arm of the X chromosome, initially near the RFLP DXS159 (7) , and more recently refined to Xql3.1, between DXS453 and DXS227 (8, 9) . Now that mutations causing SCID have been directly demonstrated in IL2RG, carrier testing and prenatal prediction can be performed with much greater certainty. A wide array of mutations in each of'the eight exons of IL2RG has been seen (10) . Moreover, newly occurring mutations can be traced to their origin, making possible accurate genetic prediction in cases where linkage analysis alone would be misleading. 'We report here a unique IL2RG mutation causing SCID in a multigeneration pedigree, in which the founder was a female germ line mosaic whose offspring inherited both mutant and wild type IL2RG genes on the same material chromosomal haplotype.
Methods
A large family of French Canadian descent included two male cousins diagnosed with SCID; one had died previously and the other died after the start of genetic evaluation. This patient was diagnosed at 6 mo of age and succumbed to complications following attempted treatment with T cell-depleted haploidentical bone marrow transplantation. A maternal uncle of the affected males was recognized in retrospect to have died of SCID at 9 mo of age following a history of failure to thrive, chronic diarrhea, and infections. A partial family pedigree is shown in Fig. 1 (11) and for PCR. Both RFLP and PCR-based microsatellite polymorphic X-linked loci were used to define the genotype of family members as described (8) . X chromosome inactivation analysis for females 1-2, 11-5, 11-6, 11-7, and I1-3 was performed as described (12) by fusing polyclonal purified T cells from each subject with hamster fibroblasts deficient in hypoxanthine phosphoribosyl transferase followed by metabolic selection for hybrid cells containing the active human X chromosome. A series of independent hybrids from each female was analyzed for DNA marker allele content by Southern blot to determine the frequency with which each X chromosome was active. T cell X inactivation in individual 1-2 was assessed by the additional method of analysis of methylation of the androgen receptor (AR) polymorphic locus as described (13) . Single strand confirmation polymorphism (SSCP) analysis of each individual exon was carried out using DNA from all available family members. A hybrid cell line containing a single X chromosome, the active X from a T cell of individual 11-7, was included in the analysis.
Preamplification of IL2RG from genomic DNA in three sections (exons 1-3, 4-5, and 6-8) was initiated with a 30 m heat soak at 945C and was performed in a thermal cycler (model 9600; Perkin Elmer-ABI, Foster City, CA). Primer sequences, shown in Table I , were derived from the published genomic sequence, GenBank accession no. L19546 (2) . Subsequent amplifications for SSCP analysis used primers flanking each exon (Table I) (2) .
Results
Genotyping. Linked markers were used to establish haplotypes for the family in the proximal long arm of the X chromosome (Fig. 1 A) . No family member had a crossover in the SCID/ IL2RG region bounded by DXS159 in Xql2 and PGK1 in Xql3.3. The closest informative flanking markers for this family were the RFLP DXS159 itself, 10.7 cM proximal to the SCID disease locus, and the microsatellite polymorphic marker locus DXS441, < 0.1 cM distal (8) . The grandpaternal (GP) haplotype of individual I-1 (Fig. 1 A) was inferred from his four daughters as { DXS 159-5.5kb, DXS441-185bp }, illustrated by a black bar in Fig. 1 A; the two X chromosomes of his wife, 1-2, had grandmaternal haplotypes { DXS159-1.6kb, DXS441-177bp } (white bar, GM1), and I DXS159-5.Skb, DXS441-175bp I (gray bar, GM2). The GM2 haplotype was inherited by the two living males, II-3 and 11-4, who both have completely normal immunity, and also by 11-5, a woman who has had two immunocompetent sons. Conversely, the GMl haplotype was passed to 11-6 and H-7, both of whom had sons affected with SCID. This same GM1 haplotype was found in the pretransplant blood sample from affected male 111-2, the only affected patient alive at the beginning of the study. The inheritance of SCID in this family could therefore most easily be explained by an IL2RG mutation on the X chromosome with the GM1 haplotype of individual 1-2; this mutation would have caused SCID in males II-1, 111-1, and III-2, and made females 11-6, 11-7, and III-3 carriers of X-linked SCID.
Individual 11-2 also inherited her mother's GM1 haplotype; she is the mother of one unaffected son (not shown); nonetheless, by linked markers she was predicted to be a carrier of Xlinked SCID.
X inactivation analysis. Multiple human T cell/hamster hybrid cell lines were generated from females in the pedigree and grown in selective conditions to isolate the active human X chromosome for determination of X inactivation patterns. Insufficient blood was available to isolate T cells for X inactivation analysis in female 11-2. Females 11-6, II-7, and 111-3 had only their paternal X chromosome as the active X in at least 17 independent hybrids. Such skewed X chromosome inactivation in T lymphocytes (designated S in Fig. 1 A) is diagnostic of female carriers of the. X-linked form of SCID, with a carrier/ non-carrier likelihood ratio of > 1,000:1 (12). As expected, female 11-5, with the GM2 maternal haplotype, had random X inactivation (R in Fig. 1 A) ; 13 hybrids had a maternal and 13 a paternal active X chromosome.
Contrary to expectation, female 1-2 was found to have random X chromosome inactivation in the hybrids made from her T cells. 11 of 13 independent hybrids (carrier/non-carrier likelihood ratio < 0.0001) contained an active X with the GML haplotype { DXS159-1.6kb, DXS441-177}, which in subsequent generations was associated with the SCID phenotype. The non-carrier pattern of random X inactivation in the T cells of I-2 was confirmed by demonstrating equal methylation of her two alleles at the differentially methylated AR (CAG)n polymorphic locus (13) SCID to multiple offspring who inherited the GM1 haplotype raised the possibility of a new germ line mutation in 1-2. Screening for IL2RG mutations. Evidence for mutation of IL2RG in the family was first sought by Northern and Southern blot analysis. Total RNA from the B cell line established before bone marrow transplantation of the affected male m1-2 showed normal quantity and size of IL2RG mRNA. This patient's genomic DNA on Southern blots with several restriction enzymes was similarly indistinguishable from normal. These negative findings indicated that the mutation in this family, like others described to date for IL2RG in SCID patients, would be a small change at the nucleotide sequence level.
Therefore, SSCP analysis was undertaken for all eight IL2RG exons amplified from genomic DNA of patient m1-2. Normal migration patterns were seen in all of his IL2RG exons except exon 5, which migrated more slowly than normal, strongly suggesting an exon 5 IL2RG mutation as the cause of SCID in this family. DNA from all available family members was subjected to exon 5 SSCP detection (Fig. 1 B) . The retarded signal from patient m1-2, seen as an upwardly shifted band marked with an asterisk in Fig. 1 B, was also seen in combination with the normally migrating band in females 11-6, II-7, and III-3, consistent with their diagnosis as heterozygous carriers of X-linked SCID. As shown, only the normal band was detected in a hybrid from 11-7 containing the active, GP X chromosome from her T cells. DNA from individuals 11-3, II-4, and II-5, who inherited only non-SCID-associated haplotypes, had only normal SSCP migration as expected.
As predicted by the random T cell inactivation analysis in female 1-2, DNA from three different hematopoetic cell lineages, including B cells (shown), T cells, and granulocytes, had no trace of the upper, mutant IL2RG exon 5 band. Moreover, her daughter, 11-2, likewise had only the normal SSCP band, indicating that she had inherited a non-mutant IL2RG gene on the same GMl haplotype as the mutant IL2RG alleles inherited by her two carrier sisters.
Sequence analysis. Exon 5 of IL2RG was sequenced directly using PCR products from genomic DNA of the affected boy 111-2 and his relatives. A 9-bp duplication insertion of cDNA nucleotides 717-725 was found, predicted to result in the duplication of amino acids 235-237 (Fig. 2) . The three female carriers, 11-6, 11-7, and III-3 had both duplicated and normal IL2RG sequence, while all other living family members, including 1-2 and II-2, had only normal sequence.
Discussion
Identification of the gene which is defective in X-linked SCID has made possible the direct detection of mutations in individuals at risk. While indirect approaches have been useful for prenatal prediction and carrier testing for many SCID families, in other families suitable pedigree structure or samples to establish X-linked inheritance may be lacking. Furthermore, the possibility of germ line mosaicism cannot be addressed by linkage analysis.
In the family reported here, a mutation in IL2RG was traced to a female founder whose somatic cells showed no mutation at the level of resolution of PCR in our SSCP analysis. The lack of mutation in her T cells was in accord with her random X chromosome inactivation. DNA from B cells and granulocytes were also non-mutant, but other non-hematopoetic tissues were not available for testing; thus some degree of somatic mosaicism cannot be ruled out. However, her descendants' genotypes clearly indicate that she had both mutant and wild type cells in her oocyte progenitors. Direct detection of the mutation by SSCP and by targeted DNA sequencing of the abnormal exon proved that the founder 1-2 had passed both wild type and mutant IL2RG genes to her offspring on the same X chromosomal haplotype.
Indirect carrier prediction based on linked marker alleles and haplotype analysis has been a pillar of genetic management, recognizing the limitation that an incorrect result may be obtained in a situation where new mutations or germ line mosaicism are present. In the family in this report, individual 11 Fig. 2 shows the protein domains of the IL2AG gene, including the four cysteine residues with conserved spacing, the "WSXWS" motif in exon 5 and the transmembrane region, all of which define IL2RG as a member of the cytokine receptor supergene family. SSCP analysis of genomic DNA from our SCID patient and carrier family members followed by direct sequencing of PCk products revealed a nine nucleotide in-frame duplication insertion in IL2RG exon 5. The mechanism for this mutation is likely to have involved gap repair following replication-associated mispairing of the five nucleotide inverted repeat sequence "AAGTG. . .GTGAA", which surrounds the duplicated bases (see cDNA 710-731, Fig. 2) (21) . The resulting predicted protein sequence has a duplication of three extracellular amino acids (glutamine, histidine, and tryptophan) just adjacent to and including the first tryptophan of the WSXWS motif. Preliminary results of flow cytometric analysis with an antibody to the IL-2 receptor -y chain (IL-2Ry) show detectable protein on the surface of EBV-transformed B cells from the patient (Puck, J. M., manuscript in preparation); thus production and expression of an abnormal IL-2Ry protein appears to occur as a result of this mutation.
Although the precise nature of the immunologic lesion produced by the duplication of these three amino acids in IL-2Ry has not been determined, two other SCID-affected patients have been reported with point mutations causing amino acid substitutions in the second tryptophan and serine of the WSXWS sequence (22) as shown in Fig. 2 . Furthermore, several observations on naturally occurring (23) and experimental mutation of the WSXWS region in receptors related to IL-2Ry, including the chain of LL-2 receptor (24) and receptors for growth hormone (23) , erythropoietin (25) , and granulocyte-macrophage colony stimulating factor (26), indicate that changes in and adjacent to this motif invariably disrupt receptor function.
IL-2Ry. is found in multiple cytokine receptor complexes, including IL-2, IL-4, and IL-7 receptors (27) (28) (29) . While IL-2 is the major T cell stimulatory cytokine, IL-4 induces B cell class switching, and IL-7 is a growth factor for both thymocytes and pre-B cells. Although neither the precise role of IL-2Ry in cytokine responses nor the disruptive effect of specific mutations such as the one in this family are yet understood, the wealth of distinct IL2RG mutations in X-linked SCID patients such as ours will facilitate dissection of the relative contribution of each cytokine in producing the SCID phenotype.
